HIV-1感染女性抗逆转录病毒治疗一年后细菌失调、宫颈阴道人乳头瘤病毒及炎症的持续存在
该纵向观察性试验纳入83例未接受抗逆转录病毒治疗(ART)的乌干达HIV-1感染女性,在ART启动后0、8、24、52周采样,评估阴道免疫微环境、宫颈阴道微生物组及HPV感染情况。结果显示,ART虽使血浆炎症标志物迅速下降,但宫颈阴道细菌多样性未改变、炎症标志物持续升高、高危和低危HPV型别流行率保持稳定,提示单纯抑制HIV-1复制不足以逆转菌群失调、促炎免疫环境及持续HPV感染。
要点
- ART一年内宫颈阴道细菌多样性未变,加德纳菌属持续高丰度。
- 宫颈阴道炎症标志物持续升高,尽管血浆炎症标志物迅速下降。
- 高危和低危HPV型别流行率在ART期间保持稳定。
核心结论
- 抑制HIV-1复制不足以逆转宫颈阴道菌群失调、促炎免疫环境及持续HPV感染。
研究设计与样本
- 纵向观察性试验纳入83例未接受ART的乌干达HIV-1感染女性,在ART启动后0、8、24、52周进行临床评估并采集宫颈阴道分泌物和血浆。
主要发现
- 加德纳菌属为最优势菌属,ART前中位相对丰度为35%,整个研究期间保持高流行率。
- ART后阴道细菌多样性无变化,但包括细菌性阴道病相关细菌消化链球菌属和普雷沃菌属在内的部分菌属相对丰度较基线下降。
- 尽管血浆炎症标志物迅速下降,宫颈阴道腔炎症标志物仍持续升高。
- 高危和低危HPV型别的流行率在ART期间保持稳定。
临床怎么用
- 对于HIV-1感染女性,即使ART有效抑制病毒复制,仍需关注宫颈阴道菌群失调、局部炎症及HPV持续感染,并考虑针对性恢复黏膜免疫功能的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The cervicovaginal microbiome may affect susceptibility to human immunodeficiency virus (HIV) -1 and can in turn influence the prevalence and clinical course of HIV-1 and other sexually transmitted diseases. Because the determinants, immunological correlates, and clinical effects of the dysbiosis observed in women with HIV-1 (WWH) remain elusive, we evaluated the vaginal immunological milieu, cervicovaginal microbiome, and prevalence of human papillomaviruses (HPVs) in antiretroviral-naive WWH over their first year of antiretroviral therapy (ART). METHODS: 83 ART-naive Ugandan WWH were enrolled in a longitudinal observational trial. Clinical evaluation and sampling of cervicovaginal secretions and plasma were performed 0, 8, 24, and 52 weeks after ART initiation. 16S ribosomal-RNA-V3-V4 sequencing identified cervicovaginal microbial communities. A multiplex-bead-array assay was used for biomarkers quantification, while a polymerase chain reaction-based hybridization assay was used for HPV genotyping. RESULTS: Gardnerella was the most abundant genus, with a median relative abundance of 35% before ART, maintaining a high prevalence throughout the study. Vaginal bacterial diversity did not change after ART, although the relative abundance of some genera, including the bacterial vaginosis-associated bacteria Peptostreptococcus and Prevotella, decreased compared with baseline. Inflammatory biomarkers remained elevated in the cervicovaginal compartment despite prompt decreases in plasma. The prevalence of high-risk and low-risk HPV types remained stable despite ART. CONCLUSIONS: Suppression of HIV-1 replication is not sufficient to revert dysbiotic changes, proinflammatory immunological milieu and persistent HPV infections. Exploration of targeted strategies to restore cervicovaginal mucosal immunological functions in WWH is warranted.
引用
- Lisco A, Borgognone A, Vanpouille C, et al. Persistence of Bacterial Dysbiosis, Cervicovaginal Human Papillomaviruses, and Inflammation in Women Living With HIV-1 After a Year of Antiretroviral Therapy. J Infect Dis. 2026. PMID: 41999406. doi:10.1093/infdis/jiag211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。